Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China flag China · Delayed Price · Currency is CNY
32.84
+1.37 (4.35%)
Feb 2, 2026, 4:00 PM EST

SHE:301281 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
429.26457.46445.94442.31419.67365.95
Other Revenue
6.266.261.640.551.221.11
435.52463.72447.58442.87420.89367.06
Revenue Growth (YoY)
-0.52%3.60%1.06%5.22%14.67%18.02%
Cost of Revenue
210.85266.76240.86264.82246.14187.25
Gross Profit
224.67196.96206.73178.04174.75179.81
Selling, General & Admin
134.26116.1299.7256.0363.171.71
Research & Development
48.9635.8243.8626.9724.4327.84
Other Operating Expenses
10.934.194.365.34.475.33
Operating Expenses
195.3156.42148.2589.1492.11103.96
Operating Income
29.3740.5458.4888.9182.6475.85
Interest Expense
-0.05-0.04----1.83
Interest & Investment Income
10.2415.415.971.330.960.11
Currency Exchange Gain (Loss)
-0.59-0.591.151.55-1.11-0.55
Other Non Operating Income (Expenses)
5.51-2.030.09-0.320.05-0.38
EBT Excluding Unusual Items
44.4853.2975.791.4782.5573.2
Gain (Loss) on Sale of Investments
0.390.80.54---
Gain (Loss) on Sale of Assets
-0.76-0.840.040.37-0.04-0.09
Asset Writedown
-1.84-----
Legal Settlements
-0.14-0.14----
Other Unusual Items
12.6112.613.456.477.417.97
Pretax Income
54.7465.7179.7498.389.9281.08
Income Tax Expense
2.765.442.77.0211.7512.43
Net Income
52.0660.2777.0491.2878.1768.65
Net Income to Common
52.0660.2777.0491.2878.1768.65
Net Income Growth
3.77%-21.77%-15.60%16.77%13.87%127.73%
Shares Outstanding (Basic)
108108101818181
Shares Outstanding (Diluted)
108108101818181
Shares Change (YoY)
-0.45%6.18%24.38%0.53%-0.47%0.34%
EPS (Basic)
0.480.560.761.120.960.84
EPS (Diluted)
0.480.560.761.120.960.84
EPS Growth
4.24%-26.32%-32.14%16.15%14.40%126.95%
Free Cash Flow
-248.07-356.9-33.1284.7531.8398.04
Free Cash Flow Per Share
-2.31-3.32-0.331.040.391.20
Dividend Per Share
0.2000.2000.3000.286--
Dividend Growth
-33.33%-33.33%5.00%---
Gross Margin
51.59%42.47%46.19%40.20%41.52%48.99%
Operating Margin
6.74%8.74%13.06%20.08%19.63%20.66%
Profit Margin
11.95%13.00%17.21%20.61%18.57%18.70%
Free Cash Flow Margin
-56.96%-76.96%-7.40%19.14%7.56%26.71%
EBITDA
68.4383.84107.43122.54109.5101.2
EBITDA Margin
15.71%18.08%24.00%27.67%26.02%27.57%
D&A For EBITDA
39.0643.348.9533.6326.8625.35
EBIT
29.3740.5458.4888.9182.6475.85
EBIT Margin
6.74%8.74%13.06%20.08%19.63%20.66%
Effective Tax Rate
5.04%8.27%3.38%7.14%13.06%15.33%
Revenue as Reported
435.52463.72447.58442.87420.89367.06
Advertising Expenses
-4.031.89---
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.